Article
An overview of genetic services delivery for hereditary breast cancer.
Breast cancer research and treatment - 1 Feb 2022
Reid Sonya, Spalluto Lucy B, Lang Katie, Weidner Anne, Pal Tuya
Abstract excerpt
Breast cancer is the most common cancer diagnosed in women worldwide, with approximately 5-10% of cases attributed to high penetrance hereditary breast cancer (HBC) genes. The tremendous advances in precision oncology have broadened indications for germline genetic testing to guide both systemic and surgical treatment, with increasing demand for cancer genetic services. The HBC continuum of care includes (1)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
